Cutera Inc CUTR
We take great care to ensure that the data presented and summarized in this overview for CUTERA INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CUTR
View all-
Pura Vida Investments, LLC New York, NY1.17MShares$384,6140.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA915KShares$301,8270.0% of portfolio
-
Voce Capital Management LLC San Francisco, CA832KShares$274,43726.32% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny764KShares$252,1730.0% of portfolio
-
Hawk Ridge Capital Management LP Los Angeles, CA445KShares$146,8190.02% of portfolio
-
Black Rock Inc. New York, NY401KShares$132,2250.0% of portfolio
-
Mario Gabelli Gamco Investors, Inc. Et Al | Rye, Ny352KShares$116,0280.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY327KShares$107,8340.01% of portfolio
-
Bank Of Montreal Toronto, A6283KShares$93,2920.0% of portfolio
-
Gabelli Funds LLC Rye, NY246KShares$81,0480.0% of portfolio
Latest Institutional Activity in CUTR
Top Purchases
Top Sells
About CUTR
Cutera, Inc., a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis. It also provides enlighten platform, a laser system that is used for tattoo removal, as well as to treat benign pigmented lesions and acne scars; excel HR platform, a hair removal solution for various skin types; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company distributes skincare products; and offers post-warranty services through extended service contracts or direct billing. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; and Pearl and Pearl Fractional hand pieces, as well as sells hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was incorporated in 1988 and is headquartered in Brisbane, California.
Insider Transactions at CUTR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
20
-0.11%
|
$0
$0.44 P/Share
|
Nov 13
2024
|
Stephana Eilene Patton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,161
-2.7%
|
$0
$0.36 P/Share
|
Nov 07
2024
|
Taylor C. Harris Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,794
-1.44%
|
$0
$0.51 P/Share
|
Nov 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
19
-0.11%
|
$0
$0.59 P/Share
|
Oct 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
20
-0.11%
|
$0
$0.79 P/Share
|
Sep 01
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-1.89%
|
$0
$0.66 P/Share
|
Sep 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
19
-0.11%
|
$0
$0.66 P/Share
|
Aug 07
2024
|
Taylor C. Harris Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,178
-5.43%
|
$15,178
$1.03 P/Share
|
Aug 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22
-0.12%
|
$22
$1.3 P/Share
|
Aug 01
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
99
-1.84%
|
$99
$1.3 P/Share
|
Jul 19
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
440
-2.4%
|
$440
$1.59 P/Share
|
Jul 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
23
-0.13%
|
$23
$1.5 P/Share
|
Jul 01
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-1.82%
|
$100
$1.5 P/Share
|
Jun 01
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
100
-1.79%
|
$200
$2.23 P/Share
|
Jun 01
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22
-0.12%
|
$44
$2.23 P/Share
|
May 16
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
24,940
-100.0%
|
$49,880
$2.59 P/Share
|
May 15
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
27,815
-52.72%
|
$55,630
$2.67 P/Share
|
May 14
2024
|
Michael Karavitis EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
10,848
-17.06%
|
$21,696
$2.45 P/Share
|
May 13
2024
|
Sheila Hopkins Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,722
-16.89%
|
$15,444
$2.04 P/Share
|
May 13
2024
|
Stuart Drummond Interim CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,015
-5.24%
|
$2,030
$2.23 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 80K shares |
---|
Payment of exercise price or tax liability | 33.3K shares |
---|---|
Open market or private sale | 63.6K shares |